Comparison between alpha-galactosidase A activity in blood samples collected on filter paper, leukocytes and plasma

Clinical Biochemistry

Volumn 45, Issue 15, 2012, Pages 1233-1238

  Daitx, Vanessa Vitcoski ^a   Mezzalira, Jamila ^a   Goldim, Mariana Pereira de Souza ^a   Coelho, Janice Carneiro ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Alpha galactosidase A; Enzyme activity; Fabry disease; Inborn errors of metabolism

Indexed keywords

ALPHA GALACTOSIDASE; BIOMATERIAL;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRIED BLOOD SPOT TESTING; ELECTRONICS; ENZYME ACTIVITY; FABRY DISEASE; FEMALE; FLUOROMETRY; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; PLASMA; PRIORITY JOURNAL; RELIABILITY; SCREENING;

ADOLESCENT; ADULT; ALPHA-GALACTOSIDASE; BLOOD SPECIMEN COLLECTION; CASE-CONTROL STUDIES; DRIED BLOOD SPOT TESTING; FABRY DISEASE; FEMALE; HUMANS; LEUKOCYTES; MALE; PAPER; PLASMA; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84866294957     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.04.030     Document Type: Article

References (23)

1. Desnick R.J., Ioannou Y.A., Eng C.M. Alpha-galactosidase A deficiency: Fabry disease. The metabolic & molecular bases of inherited disease 2001, 3733-3774. McGraw-Hill, New York; London. C.R. Scriver, A.L. Beaudet, W.S. Sly (Eds.).
2. Germain D.P. Fabry disease. Orphanet J Rare Dis 2010, 5:30.
3. Spada M., Pagliardini S., Yasuda M., et al. High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet 2006, 79:31-40.
4. Hwu W.L., Chien Y.H., Lee N.C., et al. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum Mutat 2009, 30:1397-1405.
5. Lin H.Y., Chong K.W., Hsu J.H., et al. High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet 2009, 2:450-456.
6. Desnick R.J. Prenatal diagnosis of Fabry disease. Prenat Diagn 2007, 27:693-694.
7. Linthorst G.E., Vedder A.C., Aerts J.M., Hollak C.E. Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers. Clin Chim Acta 2005, 353:201-203.
8. Nakamura K., Hattori K., Endo F. Newborn screening for lysosomal storage disorders. Am J Med Genet C Semin Med Genet 2011, 157:63-71.
9. Chamoles N.A., Blanco M., Gaggioli D. Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin Chim Acta 2001, 308:195-196.
10. Civallero G., Michelin K., de Mari J., et al. Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseases. Clin Chim Acta 2006, 372:98-102.
11. Desnick R.J., Brady R., Barranger J., et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003, 138:338-346.
12. Rodrigues M.D., de Oliveira A.C., Muller K.B., Martins A.M., D'Almeida V. Chitotriosidase determination in plasma and in dried blood spots: a comparison using two different substrates in a microplate assay. Clin Chim Acta 2009, 406:86-88.
13. de Castilhos C.D., Mezzalira J., Goldim M.P., Coelho J.C. Influence of pre-analytical factors on alpha-galactosidase A, arylsulfatase B and alpha-glucosidase activities measured on dried blood spots on filter paper. Clin Biochem 2011, 44:922-926.
14. Wenger D.A., Coppola S., Liu S.L. Insights into the diagnosis and treatment of lysosomal storage diseases. Arch Neurol 2003, 60:322-328.
15. Desnick R.J., Allen K.Y., Desnick S.J., Raman M.K., Bernlohr R.W., Krivit W. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med 1973, 81:157-171.
16. Skoog W.A., Beck W.S. Studies on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes. Blood 1956, 11:436-454.
17. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
18. Hoffmann B., Georg Koch H., Schweitzer-Krantz S., Wendel U., Mayatepek E. Deficient alpha-galactosidase A activity in plasma but no Fabry disease - a pitfall in diagnosis. Clin Chem Lab Med 2005, 43:1276-1277.
19. Andrade J., Waters P.J., Singh R.S., et al. Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test. Clin J Am Soc Nephrol 2008, 3:139-145.
20. Olivova P., van der Veen K., Cullen E., et al. Effect of sample collection on alpha-galactosidase A enzyme activity measurements in dried blood spots on filter paper. Clin Chim Acta 2009, 403:159-162.
21. Linthorst G.E., Bouwman M.G., Wijburg F.A., Aerts J.M., Poorthuis B.J., Hollak C.E. Screening for Fabry disease in high-risk populations: a systematic review. J Med Genet 2010, 47:217-222.
22. Fuller M., Lovejoy M., Brooks D.A., Harkin M.L., Hopwood J.J., Meikle P.J. Immunoquantification of alpha-galactosidase: evaluation for the diagnosis of Fabry disease. Clin Chem 2004, 50:1979-1985.
23. Caudron E., Germain D.P., Prognon P. Fabry disease: enzymatic screening using dried blood spots on filter paper. Rev Med Interne 2010, 31(Suppl. 2):S263-S269.